Clinical Trial Design for Cellular and Gene Therapy

Why UniQure's Etranacogene dezaparvovec Gene Therapy Still Holds A Promise For Hemophilia B Patients With Unmet Medical Needs

Uniqure hemophilia B gene therapy program On Clinical hold by the U.S. Food and Drug Administration (FDA)

Lilly Acquires Prevail Therapeutics-AAV9 Based Gene Therapy Company

Uniqure: Portfolio, Stock & Financial Analysis

Homology Medicine Growth Rely On Successful Phenylketonuria (PKU) Gene Therapy Program

Beam Therapeutics (Nasdaq: BEAM) Portfolio, Stock and Growth

Orchard Therapeutics: European Medicines Approves Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)

Biomarin Pharmaceuticals: Vosoritide (BMN111) for the Treatment of Achondroplasia (Short Stature)

Orchard Therapeutics: Clinical Study on Gene Therapy for Metachromatic Leukodystrophy (MLD)

Orchard Therapeutics: Clinical Study on Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA

UniQure Hope B Clinical Trial: Etranacogene dezaparvovec (AAV5-FIX-Padua Gene Therapy) Showed Substantial Improvement in Bleeding in Subjects with Hemophilia B

Bluebird Bio's: Lentiglobulin Infusion Showed Durable Expression of Modified Form Functional Beta-Globin in Sickle Cell Disease

CTX001: CRISPR Therapeutics and Vertex Present Positive Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies

Three Hot CRISPR based Gene Editing Companies ( CRSP, EDIT, NTLA)

Step Wise Protocol For Preparation of Adeno-Associated Virus Luciferase Stock

Labeling and Visualization of Mitochondria Using Mitotracker

Labeling and Visualization of Endoplasmic reticulum using ER Tracker

Labeling and Visualization of Lysosome using Lysotracker

Pages You May Like